Fundraising Fox

Innovus Pharmaceuticals

San Diego, US · Nevada corporation

Founders & leadership

BD
Bassam DamajPresident, Secretary and Treasurer
VL
Vivian LiuExecutive
WB
Wallace BoyackAll are prior status, not present status.

Board

HE
Henry EsberBoard director
ZM
Ziad MirzaBoard director

Reported raises · per SEC filings

Form D private placements

$8.3M disclosed across 8 of 10 rounds · 2012–2019

$3.2MraisedJan 2019 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Bassam DamajExecutive Officer, Director
  • Ziad MirzaDirector
  • Vivian LiuDirector
  • Ryan SelhornExecutive Officer
  • Randy BerholtzExecutive Officer
  • Dean NuhailyDirector
  • Henry EsberDirector
Offering amount
$3.2M
Amount sold
$3.2M
Sales commissions
$354.6K
Placement agents
H.C. WAINWRIGHT and CO., LLC
First sale
Jan 2019
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$145.2KraisedAug 2017 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Bassam DamajExecutive Officer, Director
Offering amount
$145.2K
Amount sold
$145.2K
First sale
Jul 2017
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3MraisedAug 2016 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Bassam DamajExecutive Officer
Offering amount
$3M
Amount sold
$3M
Minimum investment
$250K
First sale
Jun 2016
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$500KraisedAug 2015 · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Ziad MirzaDirector
  • Henry EsberDirector
  • Bassam DamajExecutive Officer, Director
  • Vivian LiuDirector
Offering amount
$1.5M
Amount sold
$500K
First sale
Aug 2015
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$16KraisedAug 2015 · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Vivian LiuDirector
  • Ziad MirzaDirector
  • Henry EsberDirector
  • Bassam DamajExecutive Officer, Director
Offering amount
$16K
Amount sold
$16K
First sale
Aug 2015
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$742.3KraisedFeb 2014 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Bassam DamajExecutive Officer, Director
  • Henry EsberDirector
  • Vivian LiuDirector
Offering amount
$742.3K
Amount sold
$742.3K
First sale
Feb 2014
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$330KraisedFeb 2014 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Bassam DamajExecutive Officer, Director
  • Vivian LiuDirector
  • Ziad MirzaDirector
  • Henry EsberDirector
Offering amount
$330K
Amount sold
$330K
Minimum investment
$300K
First sale
Feb 2014
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$350KraisedJan 2014 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Bassam DamajExecutive Officer, Director
  • Henry EsberDirector
  • Ziad MirzaDirector
  • Vivian LiuDirector
Offering amount
$350K
Amount sold
$350K
Minimum investment
$350K
First sale
Dec 2013
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

Who founded Innovus Pharmaceuticals?
Innovus Pharmaceuticals was founded by Bassam Damaj.
How much funding has Innovus Pharmaceuticals raised?
Innovus Pharmaceuticals has disclosed $8.3M raised across 8 of its 10 known rounds.
Where is Innovus Pharmaceuticals headquartered?
Innovus Pharmaceuticals is headquartered in San Diego, US.